Last reviewed · How we verify

Triptorelin plus daily FSH anh LH

Bioroma · FDA-approved active Small molecule Quality 2/100

Triptorelin plus daily FSH anh LH is a Small molecule drug developed by Bioroma. It is currently FDA-approved.

At a glance

Generic nameTriptorelin plus daily FSH anh LH
SponsorBioroma
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Triptorelin plus daily FSH anh LH

What is Triptorelin plus daily FSH anh LH?

Triptorelin plus daily FSH anh LH is a Small molecule drug developed by Bioroma.

Who makes Triptorelin plus daily FSH anh LH?

Triptorelin plus daily FSH anh LH is developed and marketed by Bioroma (see full Bioroma pipeline at /company/bioroma).

What development phase is Triptorelin plus daily FSH anh LH in?

Triptorelin plus daily FSH anh LH is FDA-approved (marketed).

Related